Sort
48,018 grants matching “immunotherapy”
Clinical Cancer Cytogenetics
$977,708Diane C Arthur · Basic Sciences · Z01 · FY2007 · CA
Immunoglobulin Replacement Therapy and Infectious Complications After CD19-Targeted CAR-T-Cell Therapy
$977,273Joshua Aiden Hill · Fred Hutchinson Cancer Center · R01 · FY2025 · CA
Developing novel targeted therapeutics integrated with immunotherapy-based approaches to make breakthroughs in metastatic breast cancer
$977,015Jean Zhao · Dana-Farber Cancer Inst · R35 · FY2019 · CA
The TGFÃÂÃÂÃÂÃÂÃÂÃÂÃÂò Signaling Pathway in Development and Cancer
$976,871Joan Massague · Sloan-Kettering Inst Can Research · R35 · FY2024 · CA
The Role of Host Factors in HIV Immunopathogenesis
$976,696Anthony S. Fauci · National Institute Of Allergy And Infectious Diseases · Z01 · FY2008 · AI
Combining receptor-targeted alpha particle therapy and immunotherapy to achieve complete responses in metastatic melanoma
$976,668Michael King Schultz · Viewpoint Molecular Targeting, Inc. · R44 · FY2022 · CA
Development of Ciclopirox Prodrug as a Novel Systemic Treatment for High-Risk Non-Muscle Invasive Bladder Cancer
$976,393William Mc Culloch · Ciclomed, Llc · R44 · FY2021 · CA
Integrating targeted therapy and immunotherapy to break through cancer
$976,251Jean Zhao · Dana-Farber Cancer Inst · R35 · FY2024 · CA
Animal models to study the role of INK4b loss in human acute myeloid leukemia
$976,228Linda Wolff · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA
Understanding and Addressing Cancer Health Disparities in Louisiana
$976,081Augusto C Ochoa · Lsu Health Sciences Center · P20 · FY2018 · CA
Impact of IL-15 immunotherapy on tissue-specific CD8 T cells to reduce the CNS HIV reservoir seeding and persistence
$975,768Lydie Trautmann · Henry M. Jackson Fdn For The Adv Mil/Med · R01 · FY2024 · MH
Animal models to study the role of INK4b loss in human acute myeloid leukemia
$975,365Linda Wolff · Division Of Basic Sciences - Nci · ZIA · FY2011 · CA
A blueprint for neutrophil heterogeneity and reprogramming in cancer
$975,000Chengcheng Jin · University Of Pennsylvania · DP2 · FY2025 · CA
Interaction between nuclear epigenetic and metabolic pathways in cancer
$975,000Shelley L Berger · University Of Pennsylvania · R35 · FY2022 · CA
Intratumoral immunotherapy with formulated resiquimod for metastatic melanoma
$974,959Yen Tun Wang · Curebiotech, Inc. · R44 · FY2020 · CA
Novel Stem Cell Immunotherapy for MDR-Tuberculosis
$974,750Chinnaswamy Jagannath · Methodist Hospital Research Institute · R01 · FY2021 · AI
Apoptotic Donor Leukocytes to Promote Kidney Transplant Tolerance
$974,638Bernhard Josef Hering · University Of Minnesota · U19 · FY2024 · AI
Effects of systemic and topical perturbations on human microbes
$974,626Heidi Kong · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA
Impact of IL-15 immunotherapy on tissue-specific CD8 T cells to reduce the CNS HIV reservoir seeding and persistence
$974,407Lydie Trautmann · Henry M. Jackson Fdn For The Adv Mil/Med · R01 · FY2023 · MH
Interaction between nuclear epigenetic and metabolic pathways in cancer
$974,274Shelley L Berger · University Of Pennsylvania · R35 · FY2025 · CA
Precision quality check of immunotherapeutics via single-cell cytokine mapping
$974,208Jing Zhou · Isoplexis, Inc. · R44 · FY2017 · CA
Modeling Combination Immunotherapy for HIV Cure in Humanized Mouse Models
$974,093James L Riley · University Of Pennsylvania · U19 · FY2022 · AI
Impact of IL-15 immunotherapy on tissue-specific CD8 T cells to reduce the CNS HIV reservoir seeding and persistence
$974,060Lydie Trautmann · Henry M. Jackson Fdn For The Adv Mil/Med · R01 · FY2025 · MH
Human natural killer cells: Advancing biology and clinical applications
$973,964Michael A Caligiuri · Beckman Research Institute/City Of Hope · R35 · FY2020 · CA
Human natural killer cells: Advancing biology and clinical applications
$973,964Michael A Caligiuri · Beckman Research Institute/City Of Hope · R35 · FY2021 · CA